Seeking Alpha Premium alternative
Seeking Alpha Premium sells a written analyst corpus that renews at $299 a year. This product computes from filings and re-tests your numbers each night.
By Javier SanzPublished Updated : Our side now reads the plans of 2026-10-06: the plan names, prices, trial and refund in the tables come from our own pricing constants, and the sentences about our product were corrected where they had gone stale. Every statement about Seeking Alpha Premium is as verified on 2026-09-18, the date in the note below.
Founder of ValueScreener. Built Ninety Nine, a securities services provider, and sold it to a tier-one global bank; ran operations and internationalization at Alpaca, the brokerage API.
Who writes thisEditorial processLinkedIn (opens in a new tab)X (opens in a new tab)
These two products are barely the same category. Seeking Alpha is a publishing platform: thousands of independent contributors arguing about specific companies in public, with comments underneath, plus a quantitative rating and a set of tools. ValueScreener publishes nothing about a company. It computes from the filings, shows its working, and watches the numbers you said had to stay true.
What both do
Both sit between a person and a US-listed company, both carry a screener, and both let you keep a list of the companies you follow. Their subscriptions page, read 2026-09-18, publishes "Stock and ETF screeners plus portfolio health and alert tools" on Premium, and "Create and track stock portfolios" on the free Basic tier.
The difference that decides it
Opinion against arithmetic, and both are legitimate inputs.
Their product is writing. A marketplace of independent analysts covering names that no small team could reach, with a comment thread under each piece, plus Quant Ratings applied across the market, earnings-call transcripts and breaking market news. That is a body of qualitative material a computed ratio table does not contain and cannot replace.
This product carries no opinion at all, by design. It reads ten years of filed statements from EDGAR, recomputes the ratios and the forensic scores itself, and opens every filed figure into its formula, its inputs, the source statement, the fiscal year and the filing date. Whether a company is worth owning is left entirely to the reader, and the regulator-safe framing is not decoration: this is a research tool and it never advises.
The second difference is the alert. Their page publishes "Price alerts and watchlists" on Basic and "portfolio health and alert tools" on Premium. A price alert fires on a price. What we could not find published on their subscriptions page as of 2026-09-18 is an alert on a numeric condition you set against a company's accounts, delivered when a newly filed statement breaks it. That is absence of published evidence, not a denial.
Here that is the product. A thesis holds your reasons in your own words and the numbers those reasons depend on. Every night, after the newest filings land, each number is recomputed and tested. One email on the day one breaks, with the arithmetic and the filing attached, and silence on every other day.
What each costs
| Seeking Alpha, as published | ValueScreener | |
|---|---|---|
| Free tier | Basic Access, "Limited Access" | Curious: screener, company pages, watchlist |
| Premium | "Only $4.95 for 1 month", "renews at $299/year" | Serious: $29/month or $299/year |
| PRO | "$99 for 1 month", "renews at $2,400/year" | Professional: $99/month or $999/year |
| Groups | "Group rates available for 10 or more employees" | No teams |
| Trial | No free trial on the subscriptions page; the published entry is a paid introductory month | 30 days of Professional, no card |
| Refund | Terms of use: "Unless stated otherwise in writing, Subscription fees are nonrefundable" | 30-day money-back guarantee on a first payment |
Their figures are quoted from their own subscriptions page and terms of use as read on 2026-09-18. The $4.95 and $99 figures are printed there as a special introductory offer for new subscribers, not as the standing price; the standing prices published on the page are $299 a year and $2,400 a year. Their terms also describe a narrower window than the flat non-refundable line suggests, and it is quoted here rather than paraphrased: "For subscription products offering a limited 30-day money back guarantee, you must cancel your subscription no later than one (1) day before the 30-day limited money back guarantee period expires in order to receive a refund for the remaining 11 months of your subscription." Which products offer it is not stated in that clause. Note the URL: the terms are served from about.seekingalpha.com/terms.
Where Seeking Alpha Premium is better
The written corpus is the product and it is not replicable. A few thousand independent contributors publishing in depth, and arguing in the comments, is a kind of coverage no computed metric substitutes for, and it reaches small and obscure US names that no ratio table describes.
Quant Ratings give a consistent cross-sectional read across the whole market in one click, which is a faster first cut than building a screen.
Earnings-call transcripts, call insights and breaking market news are first-party material sitting right next to the numbers. This product carries no transcripts, no news and no commentary.
There is a free tier, with unlimited breaking news on it, and a first month at $4.95 is a low-friction way onto a paid product. The free half here is the screener, the company pages and a watchlist, with no news at all.
They serve teams. This product has no team plan and is not going to have one.
Who should pick which
If what you are missing is other people's reasoning about a company, take theirs. If you want transcripts, news and a marketplace of analysts, the same.
If what you are missing is a defensible trail behind each figure, and a process that tells you the day your own reason breaks rather than the day a price moves, that is this product. The two are complements more often than substitutes, and plenty of readers will end up with both. Neither is advice, and neither is this page.
What this leaves out
Every claim about Seeking Alpha here was read on their own subscriptions page and terms of use on 2026-09-18. Company counts, market counts and years of financial history are not published on those pages and are therefore not stated here. Where this page says a capability was not found, that is absence of published evidence on the pages read, not a statement that it does not exist.